Sight Sciences (SGHT)

• Market cap: $141M
• 1 day: 2.24%
• 5 days: -6.16%
• 1 month: 3.79%
• 3 months: -23.25%
• 6 months: -57.91%
• Year to date: -23.46%
• 1 year: -47.10%
• 5 years: -91.82%
• 10 years: -91.82%
• Sector: Healthcare
• Industry: Surgical & Medical Instruments & Apparatus

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

8,633% more call options, than puts

Call options by funds: $262K | Put options by funds: $3K

76% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 17

50% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 12

10.32% more ownership

Funds ownership: 34.22% [Q3] → 44.54% (+10.32%) [Q4]

5% more funds holding

Funds holding: 78 [Q3] → 82 (+4) [Q4]

3% more capital invested

Capital invested by funds: $108M [Q3] → $112M (+$3.48M) [Q4]

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $2.50 9% downside
• Avg. target: $3.60 31% upside
• High target: $5 82% upside

5 analyst ratings

• positive: 2 40%
• neutral: 3 60%
• negative: 0 0%

Lake Street Frank Takkinen 50% 1-year accuracy 11 / 22 met price target	9% downside $2.50	Hold Maintained	6 Mar 2025
Stifel Thomas Stephan 40% 1-year accuracy 6 / 15 met price target	46% upside $4	Buy Maintained	6 Mar 2025
Piper Sandler Matt O'Brien 45% 1-year accuracy 22 / 49 met price target	28% upside $3.50	Neutral Maintained	6 Mar 2025
Citigroup Joanne Wuensch 43% 1-year accuracy 22 / 51 met price target	9% upside $3	Neutral Maintained	4 Mar 2025
UBS Danielle Antalffy 46% 1-year accuracy 6 / 13 met price target	82% upside $5	Buy Maintained	27 Jan 2025